SCHEMBL19523045

SCHEMBL19523045

CC[C@H](C)NC(=O)Cc1ccc(Cl)cc1

nearest known ligand 0.68

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 6/20 0.61
KMT2A Q03164 4/20 0.55
POLB P06746 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
ALDH1A1 P00352 3/20 0.51
TDP1 Q9NUW8 1/20 0.51
MEN1 O00255 2/20 0.50
PSMB8 P28062 1/20 0.50
PSMB5 P28074 1/20 0.50
LMNA P02545 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
KDM4E B2RXH2 1/20 0.49
PKM P14618 1/20 0.49
RXFP1 Q9HBX9 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18885276 0.84 CNR2 (0.67) CNR2KMT2APOLBL3MBTL1ALDH1A1
SCHEMBL19591984 0.83 POLB (0.76) CNR2KMT2APOLBL3MBTL1ALDH1A1
SCHEMBL6136364 0.81 CNR2 (0.58) CNR2KMT2AL3MBTL1ALDH1A1TDP1
SCHEMBL6136330 0.80 CNR2 (0.61) CNR2KMT2APOLBL3MBTL1ALDH1A1
SCHEMBL6136328 0.80 CNR2 (0.61) CNR2KMT2APOLBL3MBTL1ALDH1A1
SCHEMBL12835529 0.80 CNR2 (0.61) CNR2KMT2APOLBL3MBTL1ALDH1A1
SCHEMBL5327587 0.79 ALDH1A1 (0.74) CNR2KMT2APOLBALDH1A1MEN1
SCHEMBL19523041 0.79 CNR2 (0.59) CNR2KMT2AL3MBTL1ALDH1A1MEN1
SCHEMBL27528191 0.79 CNR2 (0.59) CNR2KMT2APOLBL3MBTL1ALDH1A1
SCHEMBL20099754 0.78 CNR2 (0.51) CNR2KMT2APOLBALDH1A1PSMB8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9802958-B2 Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORy and the treatment of disease LYCERA CORPORATION (US) 2017-10-31 US disclosed